Taconic Biosciences prioritizes accessibility and efficiency in preclinical research. Unlike other providers, Taconic does ...

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025 OSE-CYTOMASK®, a new ...

Edgar Lerma, MD, provides insights into the pathophysiology of IgA nephropathy (IgAN) and the therapeutic promise of ...

A risk prediction score that uses machine learning and a patient’s genetic information may identify autoimmune conditions up ...

A new peer-reviewed clinical trial conducted by researchers at Tel Aviv University and Reichman University found that ...

Frankincense essential oil is known for its anti-inflammatory, antioxidant, and therapeutic properties. A recent study ...

During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...

A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ...

A COMMON condiment could be to blame for your depression, researchers have suggested. A pinch in your cooking, a shake on ...

A review of the side effects of CAR T-cell therapy, including CRS, ICANS, tumor lysis syndrome, and late-onset toxicities, and management strategies.

Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.